Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • From the Analyst's Couch
  • Published:

The evolution of biotech

Nature Reviews Drug Discovery volume 1, pages 845–846 (2002)Cite this article

Twenty years ago, the commercial launch of recombinant insulin, the first biotechnology-derived drug, marked the birth of biotech. Today, biotech is coming into its own as a mature industry, although its growing pains are exacerbated by the current economic climate. Here, we take a look at how today's biotech industry will evolve to adapt to market dynamics. In a follow-up article next month we will look at the industry in terms of timelines, pipelines and technology.

Industry growth

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Biotech drug approval.
Figure 2: Top ten biotech companies by revenue.
Figure 3: US and European biotech growth.

Author information

Authors and Affiliations

  1. Decision Resources, Inc., 260 Charles Street, Waltham, 02453, Massachusetts, USA

    Carilee Berg, Rena Nassr & Kevin Pang

Authors
  1. Carilee Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rena Nassr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Carilee Berg is an analyst, Rena Nassr is an analyst and Kevin Pang is Vice President

Related links

Related links

DATABASES

LocusLink

insulin

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berg, C., Nassr, R. & Pang, K. The evolution of biotech. Nat Rev Drug Discov 1, 845–846 (2002). https://doi.org/10.1038/nrd944

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd944

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing